Department of Molecular Medicine, Sapienza University of Rome, Viale Regina Elena 324, 00161 Rome, Italy.
Cells. 2022 Oct 31;11(21):3435. doi: 10.3390/cells11213435.
The discovery of the skeletal muscle-specific transcription factor MyoD represents a milestone in the field of transcriptional regulation during differentiation and cell-fate reprogramming. MyoD was the first tissue-specific factor found capable of converting non-muscle somatic cells into skeletal muscle cells. A unique feature of MyoD, with respect to other lineage-specific factors able to drive trans-differentiation processes, is its ability to dramatically change the cell fate even when expressed alone. The present review will outline the molecular strategies by which MyoD reprograms the transcriptional regulation of the cell of origin during the myogenic conversion, focusing on the activation and coordination of a complex network of co-factors and epigenetic mechanisms. Some molecular roadblocks, found to restrain MyoD-dependent trans-differentiation, and the possible ways for overcoming these barriers, will also be discussed. Indeed, they are of critical importance not only to expand our knowledge of basic muscle biology but also to improve the generation skeletal muscle cells for translational research.
肌节特异性转录因子 MyoD 的发现代表了分化和细胞命运重编程过程中转录调控领域的一个里程碑。MyoD 是第一个被发现能够将非肌肉体体细胞转化为骨骼肌细胞的组织特异性因子。与其他能够驱动转分化过程的谱系特异性因子相比,MyoD 的一个独特特征是,即使单独表达,它也能够显著改变细胞命运。本综述将概述 MyoD 在成肌转化过程中重新编程细胞起源的转录调控的分子策略,重点关注复杂的共因子网络和表观遗传机制的激活和协调。还将讨论一些发现的限制 MyoD 依赖性转分化的分子障碍,以及克服这些障碍的可能方法。事实上,它们不仅对扩展我们对基本肌肉生物学的认识至关重要,而且对改善用于转化研究的骨骼肌细胞的生成也至关重要。